Peptide-containing composition for use for treating neoplastic lesions

An aqueous pharmaceutical composition, the composition comprising:

• (i) 0.5-2% w/w therapeutic oligopeptide, wherein the therapeutic oligopeptide comprises the amino acid sequence set forth in SEQ ID NO:
• 1, or an amino acid sequence having at least 85% sequence identity thereto;
• (ii) 0.5-2% w/w preservative;
• (iii) 0.5-2% w/w silicone;
• (iv) 14-16% w/w di(ethylene glycol) ethyl ether;
• (v) 0.01-0.05% w/w butylated hydroxyanisole;
• (vi) 4-6% w/w liquid paraffin;
• (vii) 5-7% w/w soft paraffin;
• (viii) 4.5-6.5% w/w cetostearyl alcohol;
• and
• (ix) 1-3% w/w polyoxyl 20 cetostearyl ether.